Markets:

Overview

News

Currencies

International

Treasuries

Globus Medical, Inc. Class A Common Stock (NY:GMED)

88.82 +1.23 (+1.40%)

Streaming Delayed Price Updated: 1:33 PM EST, Feb 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Globus Medical, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Globus Medical: Q4 Revenue Tops Forecast ↗

February 20, 2025

Globus Medical's robust earnings for Q4 2024 were driven by strategic acquisitions and sustained innovation.

Via The Motley Fool

Globus Medical’s (NYSE:GMED) Q4 Sales Beat Estimates

February 20, 2025

Medical device company Globus Medical (NYSE:GMED) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 6.6% year on year to $657.3 million. The company expects the full...

Via StockStory

Topics Earnings

Globus Medical Reports Fourth Quarter and Full Year 2024 Results

February 20, 2025

From Globus Medical

Via GlobeNewswire

Earnings Scheduled For February 20, 2025 ↗

February 20, 2025

Via Benzinga

Globus Medical (GMED) Q4 Earnings: What To Expect

February 19, 2025

Medical device company Globus Medical (NYSE:GMED) will be announcing earnings results tomorrow after the bell. Here’s what to expect.

Via StockStory

$100 Invested In Globus Medical 10 Years Ago Would Be Worth This Much Today ↗

February 10, 2025

Via Benzinga

Analyst Expectations For Globus Medical's Future ↗

February 06, 2025

Via Benzinga

Top 2 Health Care Stocks That May Crash In February ↗

February 05, 2025

Via Benzinga

Investors should take note of NYSE:GMED, a growth stock that remains attractively priced. ↗

February 07, 2025

Based on Fundamental Analysis it can be said that NYSE:GMED is a growth stock which is not overvalued.

Via Chartmill

Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients

February 06, 2025

From Globus Medical

Via GlobeNewswire

Globus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call

January 30, 2025

From Globus Medical

Via GlobeNewswire

Why NYSE:GMED is Poised for High Growth. ↗

January 29, 2025

A fundamental and technical analysis of (NYSE:GMED): Exploring GLOBUS MEDICAL INC - A (NYSE:GMED)'s high growth characteristics.

Via Chartmill

Price Over Earnings Overview: Globus Medical ↗

January 06, 2025

Via Benzinga

Why GLOBUS MEDICAL INC - A (NYSE:GMED) qualifies as a high growth stock. ↗

December 31, 2024

Delving into GLOBUS MEDICAL INC - A (NYSE:GMED)'s high Growth Prospects.

Via Chartmill

16 Analysts Have This To Say About Globus Medical ↗

December 18, 2024

Via Benzinga

Stryker Had A Good Year Last Year; Here's How It's Looking For 2025 ↗

January 13, 2025

Reflecting its strong growth, on Monday the Relative Strength (RS) Rating for Stryker stock got an upgrade from 70 to 74.

Via Investor's Business Daily

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

January 08, 2025

From Globus Medical

Via GlobeNewswire

The Law Offices of Frank R. Cruz Continues Its Investigation of Globus Medical, Inc. (GMED) on Behalf of Investors

January 08, 2025

From The Law Offices of Frank R. Cruz

Via Business Wire

Inspire Medical's Sleep Innovations Driving Big Gains ↗

January 08, 2025

Inspire Medical, which makes innovative apnea relief devices, hit a key performance benchmark as its Relative Strength Rating jumped to 81.

Via Investor's Business Daily

Should you consider GLOBUS MEDICAL INC - A (NYSE:GMED) for high growth investing? ↗

December 10, 2024

Unlocking the high Growth Potential of GLOBUS MEDICAL INC - A (NYSE:GMED).

Via Chartmill

Novocure Stock Earns 96 RS Rating ↗

December 03, 2024

On Tuesday, Novocure stock got a positive adjustment to its Relative Strength (RS) Rating to 96, up from 73.

Via Investor's Business Daily

Evaluating Globus Medical: Insights From 11 Financial Analysts ↗

December 02, 2024

Via Benzinga

Lantheus Stock Doubled In A Year Amid Wide Use Of Its AI-Enabled Medical Devices ↗

January 07, 2025

Lantheus Holdings sees its Relative Strength Rating reach the 80-plus level.

Via Investor's Business Daily

Inari Medical Stock Gets RS Rating Upgrade ↗

December 11, 2024

On Wednesday, Inari Medical stock received an upgrade to its Relative Strength (RS) Rating, from 65 to 72.

Via Investor's Business Daily

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos ↗

December 02, 2024

Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.

Via Benzinga

Globus Medical Launches ExcelsiusHub™ Navigation System

November 22, 2024

From Globus Medical

Via GlobeNewswire

What 7 Analyst Ratings Have To Say About Globus Medical ↗

November 06, 2024

Via Benzinga

Despite its growth, NYSE:GMED remains within the realm of affordability. ↗

November 07, 2024

GLOBUS MEDICAL INC - A (NYSE:GMED) stands out as a growth opportunity that won't break the bank.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 06, 2024

Via Benzinga

CVS Health, Johnson Controls And 3 Stocks To Watch Heading Into Wednesday ↗

November 06, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.